Boundless Bio, Inc.
BOLD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $310 | $317 | $0 | $0 |
| Gross Profit | -$310 | -$317 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $10,363 | $11,901 | $12,138 | $13,314 |
| G&A Expenses | $4,475 | $4,843 | $5,203 | $4,964 |
| SG&A Expenses | $4,475 | $4,843 | $5,203 | $4,964 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $14,838 | $16,744 | $17,341 | $18,278 |
| Operating Income | -$15,148 | -$17,061 | -$17,341 | -$18,278 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1,269 | $1,386 | $1,583 | $1,830 |
| Pre-Tax Income | -$13,879 | -$15,675 | -$15,758 | -$16,448 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$13,879 | -$15,675 | -$15,758 | -$16,448 |
| % Margin | – | – | – | – |
| EPS | -0.62 | -0.7 | -0.71 | -0.84 |
| % Growth | 11.4% | 1.4% | 15.5% | – |
| EPS Diluted | -0.62 | -0.7 | -0.71 | -0.84 |
| Weighted Avg Shares Out | 22,386 | 22,356 | 22,300 | 16,984 |
| Weighted Avg Shares Out Dil | 22,386 | 22,356 | 22,300 | 16,984 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,269 | $1,386 | $1,585 | $1,915 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $310 | $317 | $317 | $296 |
| EBITDA | -$13,569 | -$15,358 | -$17,024 | -$17,982 |
| % Margin | – | – | – | – |